InvestorsHub Logo
Replies to #47701 on Biotech Values
icon url

ghmm

05/31/07 6:14 AM

#47709 RE: DewDiligence #47701

They picked FOLD as the stock ticker because they claim to have expertise in protein folding, but that doesn’t mean it was a wise choice :-)
I agree but hopefully it scared off some people from investing and kept the price below fair value. At 15 they'll have a market cap in the ~300 million range (they have almost 22 million outstanding now. I've included the overallotment and about 4 million in options)

A couple interesting things the talk about the Fabry market being potentially much larger then previously thought. TKT had hinted at this and also believed (and has since been shown to be true) that women get the disease. One group, the milder form, they could probably do a better job at targeting with their drug being oral.

The company is an interesting story outside of investment purposes. The founder help get Genzyme's Pompe drug moving because his children have the disease. I just recently got the book on his story
http://www.amazon.com/Cure-Million-Medical-Establishment-Children/dp/B000OH28QI/ref=pd_bbs_sr_1/002-...
Didn't even start it yet so no recommendation.